ObsEva (OBSV) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock OBSV vs. MYMD, NCNA, NAVB, SYRS, SCPS, SMFL, VRPX, STAB, EVLO, and CMRAShould you be buying ObsEva stock or one of its competitors? The main competitors of ObsEva include MyMD Pharmaceuticals (MYMD), NuCana (NCNA), Navidea Biopharmaceuticals (NAVB), Syros Pharmaceuticals (SYRS), Scopus BioPharma (SCPS), Smart for Life (SMFL), Virpax Pharmaceuticals (VRPX), Statera Biopharma (STAB), Evelo Biosciences (EVLO), and Comera Life Sciences (CMRA). These companies are all part of the "pharmaceutical products" industry. ObsEva vs. Its Competitors MyMD Pharmaceuticals NuCana Navidea Biopharmaceuticals Syros Pharmaceuticals Scopus BioPharma Smart for Life Virpax Pharmaceuticals Statera Biopharma Evelo Biosciences Comera Life Sciences (:) and ObsEva (NASDAQ:OBSV) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Is or OBSV more profitable? 's return on equity of 0.00% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets N/A N/A N/A ObsEva N/A -416.36%-92.01% Which has better valuation and earnings, or OBSV? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioN/AN/AN/AN/AN/AObsEvaN/AN/A-$58.38M-$0.92N/A Does the media prefer or OBSV? In the previous week, had 3603 more articles in the media than ObsEva. MarketBeat recorded 3603 mentions for and 0 mentions for ObsEva. 's average media sentiment score of 0.00 equaled ObsEva'saverage media sentiment score. Company Overall Sentiment Neutral ObsEva Neutral Do institutionals and insiders hold more shares of or OBSV? 17.5% of ObsEva shares are held by institutional investors. 14.4% of ObsEva shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Summary beats ObsEva on 3 of the 5 factors compared between the two stocks. Get ObsEva News Delivered to You Automatically Sign up to receive the latest news and ratings for OBSV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBSV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBSV vs. The Competition Export to ExcelMetricObsEvaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.94M$941.20M$5.83B$10.00BDividend YieldN/A4.84%5.28%4.53%P/E Ratio0.001.1275.6926.28Price / SalesN/A26.60544.78188.18Price / CashN/A19.5637.2059.76Price / BookN/A6.7511.506.41Net Income-$58.38M-$4.20M$3.28B$270.56M ObsEva Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050MYMDMyMD PharmaceuticalsN/A$0.05-21.6%N/AN/A$114KN/A0.006Gap DownHigh Trading VolumeNCNANuCana0.7827 of 5 stars$2.98-6.6%$5,000.00+167,685.2%-99.5%$90KN/A0.0030Positive NewsNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-50.0%$50K$8.13K0.0010High Trading VolumeSYRSSyros Pharmaceuticals3.9494 of 5 stars$0.00-40.0%$1.00+83,233.3%-99.9%$32K$386K0.00120SCPSScopus BioPharmaN/A$0.00+33.3%N/A+0.0%$17KN/A0.009Gap DownSMFLSmart for LifeN/A$0.00-72.8%N/A-99.9%$16K$11.11M0.00110Gap UpVRPXVirpax Pharmaceuticals0.1027 of 5 stars$0.01flatN/A-99.9%$14KN/A0.007STABStatera BiopharmaN/A$0.00+100.0%N/A-83.3%$11KN/A0.0020Gap DownHigh Trading VolumeEVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9KN/A0.00120CMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002 Related Companies and Tools Related Companies MyMD Pharmaceuticals Alternatives NuCana Alternatives Navidea Biopharmaceuticals Alternatives Syros Pharmaceuticals Alternatives Scopus BioPharma Alternatives Smart for Life Alternatives Virpax Pharmaceuticals Alternatives Statera Biopharma Alternatives Evelo Biosciences Alternatives Comera Life Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OBSV) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredUnlock Friday's Full Potential: Two Simple Sentences that put profits in investors’ pocketsMost traders stick to the same routine each week. But a little-known market strategy has quietly delivered a 9...Eagle Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ObsEva SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ObsEva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBSV Stock Alerts